Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for ECGS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -8.953M
March 31, 2026 -8.794M
December 31, 2025 -8.843M
June 30, 2025 -7.510M
March 31, 2025 -7.397M
December 31, 2024 -7.311M
September 30, 2024 -7.094M
June 30, 2024 -6.672M
March 31, 2024 -6.565M
December 31, 2023 -6.083M
September 30, 2023 -5.625M
June 30, 2023 -5.096M
March 31, 2023 -4.956M
December 31, 2022 -4.909M
September 30, 2022 4.031M
Date Value
June 30, 2022 4.606M
March 31, 2022 4.763M
December 31, 2021 5.200M
September 30, 2021 5.625M
June 30, 2021 5.686M
March 31, 2021 5.996M
December 31, 2020 -2.234M
September 30, 2020 -2.046M
June 30, 2020 -1.640M
March 31, 2020 -1.579M
December 31, 2019 -1.752M
September 30, 2019 -1.672M
June 30, 2019 -1.670M
March 31, 2019 -1.648M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Resonate Blends, Inc. -5.364M
Breakthrough Chemistry, Inc. 0.8373M
Kaya Holdings, Inc. -0.5474M
Cardiac Biotech Solutions, Inc. -2.221M
Earth Science Tech, Inc. 7.342M

Shareholders Equity (Quarterly) Related Metrics